Diabetic Macular Edema
Diabetic macular edema (DME) is an eye disease in which there is fluid buildup in the macula. Even though diabetes is considered the significant risk factor in the pathogenesis of DME, the exact mechanism is still unclear.
Gain rich insights into Diabetic macular edema, its signs and symptoms, causes, and diagnostics tests. Learn more about its Diabetic macular edema epidemiological statistics, available Diabetic macular edema treatment scenario, and Diabetic macular edema marketed therapies available, and unmet needs in the market through our newsletter.
The Diabetic macular edema newsletter brings an overlay of the Diabetic macular edema market domain, clinical trials, and therapies in the DME pipeline that are expected to transform the Diabetic macular edema market in the coming decade.
Learn about the major pharma companies in the Diabetic macular edema therapeutics market, recent collaborations and agreements, and the happenings at the research front fueling the Diabetic macular edema market landscape.
Subscribe for more.
Know more about What's covered:
- Indication overview
- Signs, symptoms, and diagnosis
- Stages
- Treatment approaches
- Unmet needs
- Key Companies
- Market insights
- R&D in the field
- Pipeline drugs
- Support from International organizations
- Collaborations and deals in the domain
